Executive Committee

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies. ECN members are chosen by the Board of Directors.

Download the Novartis organizational structure (PDF 0.5 MB)

Chief Executive Officer of Novartis
Vasant (Vas) Narasimhan, M.D.
President of Novartis Institutes for BioMedical Research (NIBR)
James (Jay) Bradner, M.D.
Chief Legal Officer of Novartis
Karen L. Hale
Chief Financial Officer of Novartis
Harry Kirsch
Chief People & Organization Officer of Novartis
Rob Kowalski
Global Head of Novartis Technical Operations (NTO)
Steffen Lang, Ph.D.
Chief Ethics, Risk & Compliance Officer of Novartis
Klaus Moosmayer, Ph.D.
Chief Executive Officer of Sandoz
Richard Saynor
President of Novartis Oncology
Susanne Schaffert, Ph.D.
Head of Global Drug Development and Chief Medical Officer for Novartis
John Tsai, M.D.
President of Novartis Pharmaceuticals
Marie-France Tschudin
Head of Customer & Technology Solutions (CTS)
Robert Weltevreden

Other Members of Senior Management


Strategic Advisor to the CEO of Novartis
Bertrand Bodson
Group Head of Corporate Affairs and Global Health
Lutz Hegemann, M.D., Ph.D.
Global Head of Novartis Business Assurance & Advisory and Head of Internal Audit
Natacha Theytaz
Chief Communications Officer, Communications & Engagement, of Novartis
Michael Willi